New roles for an old drug: Inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates

Trends in Cardiovascular Medicine

Volumn 16, Issue 3, 2006, Pages 75-80

  Weyrich, Andrew S ^a   Kraiss, Larry W ^a   Prescott, Stephen M ^a   Zimmerman, Guy A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; CYCLOOXYGENASE 2; DIPYRIDAMOLE; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; P SELECTIN GLYCOPROTEIN LIGAND 1; RANTES; RAPAMYCIN; THROMBOCYTE ACTIVATING FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BIOACCUMULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEART MUSCLE ISCHEMIA; HUMAN; LEUKOCYTE AGGREGATION; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; STROKE; THROMBOCYTE AGGREGATION; UNSPECIFIED SIDE EFFECT;

CORONARY DISEASE; DIPYRIDAMOLE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES; P-SELECTIN; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 33645014133     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2005.12.002     Document Type: Review

References (66)

1. J Branger, B van den Blink, and S Weijer Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia Blood 101 2003 4446 4448
2. M Camera, V Toschi, and C Comparato Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin Thromb Haemost 87 2002 748 755
3. AB Carter, MM Monick, and GW Hunninghake Both Erk and p38 kinases are necessary for cytokine gene transcription Am J Respir Cell Mol Biol 20 1999 751 758
4. M Castellanos, R Leira, and J Serena Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke Stroke 34 2003 40 46
5. M Chello, P Mastroroberto, and E Malta Inhibition by dipyridamole of neutrophil adhesion to vascular endothelium during coronary bypass surgery Ann Thorac Surg 67 1999 1277 1282
6. JP De La Cruz, E Blanco, and F Sanchez de la Cuesta Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway Eur J Pharmacol 397 2000 35 41
7. HC Diener Dipyridamole trials in stroke prevention Neurology 51 1998 S17 S19
8. HC Diener, L Cunha, and C Forbes European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke J Neurol Sci 143 1996 1 13
9. WG Eisert Dipyridamole AD Michelson Platelets 2002 Academic Press San Diego 803 815
10. GA FitzGerald Dipyridamole N Engl J Med 316 1987 1247 1257
11. GA FitzGerald COX-2 and beyond: approaches to prostaglandin inhibition in human disease Nat Rev Drug Discov 2 2003 879 890
12. JE Freedman, and J Loscalzo Platelet-monocyte aggregates: bridging thrombosis and inflammation Circulation 105 2002 2130 2132
13. T Freestone, RJ Turner, and A Coady Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm Arterioscler Thromb Vasc Biol 15 1995 1145 1151
14. MI Furman, MR Barnard, and LA Krueger Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction J Am Coll Cardiol 38 2001 1002 1006
15. SW Galt, S Lindemann, and D Medd Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets Circ Res 89 2001 509 516
16. ML Giustizieri, C Albanesi, and C Scarponi Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo Am J Pathol 161 2002 1409 1418
17. SA Harding, AJ Sommerfield, and J Sarma Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus Atherosclerosis 176 2004 321 325
18. J Heusinger-Ribeiro, B Fischer, and M Goppelt-Struebe Differential effects of simvastatin on mesangial cells Kidney Int 66 2004 187 195
19. Y Huo, A Schober, and SB Forlow Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E Nat Med 9 2003 61 67
20. T Ito, and U Ikeda Inflammatory cytokines and cardiovascular disease Curr Drug Targets Inflamm Allergy 2 2003 257 265
21. H Kirii, T Niwa, and Y Yamada Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice Arterioscler Thromb Vasc Biol 23 2003 656 660
22. CW Kopp, S Steiner, and C Nasel Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting Stroke 34 2003 2560 2567
23. JC Lee, JT Laydon, and PC McDonnell A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 1994 739 746
24. HA Lehr, AS Weyrich, and RK Saetzler Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking [see comments] J Clin Invest 99 1997 2358 2364
25. P Libby Inflammation in atherosclerosis Nature 420 2002 868 874
26. SW Lindemann, AS Weyrich, and GA Zimmerman Signaling to translational control pathways: diversity in gene regulation in inflammatory and vascular cells Trends Cardiovasc Med 15 2005 9 17
27. IM Loftus, AR Naylor, PR Bell, and MM Thompson Plasma MMP-9-a marker of carotid plaque instability Eur J Vasc Endovasc Surg 21 2001 17 21
28. M Matsumoto, D Einhaus, ES Gold, and A Aderem Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors J Immunol 172 2004 7377 7384
29. TA McKinsey, and EN Olson Toward transcriptional therapies for the failing heart: chemical screens to modulate genes J Clin Invest 115 2005 538 546
30. AD Michelson, MR Barnard, and HB Hechtman In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function Proc Natl Acad Sci U S A 93 1996 11877 11882
31. AD Michelson, MR Barnard, and LA Krueger Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction Circulation 104 2001 1533 1537
32. M Minhajuddin, F Fazal, and KM Bijli Inhibition of mammalian target of rapamycin potentiates thrombin-induced intercellular adhesion molecule-1 expression by accelerating and stabilizing NF-kappa B activation in endothelial cells J Immunol 174 2005 5823 5829
33. JW Moses, MB Leon, and JJ Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
34. H Nakagami, KS Jensen, and JK Liao A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms Ann Med 35 2003 398 403
35. FJ Neumann, N Marx, and M Gawaz Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets Circulation 95 1997 2387 2394
36. KM Newman, AM Malon, and RD Shin Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources Connect Tissue Res 30 1994 265 276
37. J Nijm, A Wikby, and A Tompa Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease Am J Cardiol 95 2005 452 456
38. SN Nikas, and AA Drosos SCIO-469 Scios Inc Curr Opin Investig Drugs 5 2004 1205 1212
39. S Okie Raising the safety bar-the FDA's coxib meeting N Engl J Med 352 2005 1283 1285
40. K Ono, and J Han The p38 signal transduction pathway: activation and function Cell Signal 12 2000 1 13
41. C Pargellis, and J Regan Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis Curr Opin Investig Drugs 4 2003 566 571
42. A Pietersma, BC Tilly, and M Gaestel p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level Biochem Biophys Res Commun 230 1997 44 48
43. R Pyo, JK Lee, and JM Shipley Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms J Clin Invest 105 2000 1641 1649
44. MD Rekhter Collagen synthesis in atherosclerosis: too much and not enough Cardiovasc Res 41 1999 376 384
45. MD Rekhter, E O'Brien, and N Shah The importance of thrombus organization and stellate cell phenotype in collagen I gene expression in human, coronary atherosclerotic and restenotic lesions Cardiovasc Res 32 1996 496 502
46. PM Ridker, M Cushman, and MJ Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
47. NP Riksen, WJ Oyen, and BP Ramakers Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans Clin Pharmacol Ther 78 2005 52 59
48. MP Rivey, MR Alexander, and JW Taylor Dipyridamole: a critical evaluation Drug Intell Clin Pharm 18 1984 869 880
49. RD Rudic, D Brinster, and Y Cheng COX-2-derived prostacyclin modulates vascular remodeling Circ Res 96 2005 1240 1247
50. J Sarma, CA Laan, and S Alam Increased platelet binding to circulating monocytes in acute coronary syndromes Circulation 105 2002 2166 2171
51. Y Sheikine, and GK Hansson Chemokines and atherosclerosis Ann Med 36 2004 98 118
52. WS Shin, A Szuba, and SG Rockson The role of chemokines in human cardiovascular pathology: enhanced biological insights Atherosclerosis 160 2002 91 102
53. SS Smyth, ED Reis, and W Zhang Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury Circulation 103 2001 2501 2507
54. A Tailor, and DN Granger Hypercholesterolemia promotes leukocyte-dependent platelet adhesion in murine postcapillary venules Microcirculation 11 2004 597 603
55. M Taniguchi, S Magata, and T Suzuki Dipyridamole protects the liver against warm ischemia and reperfusion injury J Am Coll Surg 198 2004 758 769
56. EJ Topol Aspirin with bypass surgery-from taboo to new standard of care N Engl J Med 347 2002 1359 1360
57. CJ Vaughan, and AM Gotto Jr. Update on statins: 2003 Circulation 110 2004 886 892
58. BB Weksler Antiplatelet agents in stroke prevention. Combination therapy: present and future Cerebrovasc Dis 10 Suppl 5 2000 41 48
59. AS Weyrich, TM McIntyre, and RP McEver Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation [see comments] J Clin Invest 95 1995 2297 2303
60. AS Weyrich, MR Elstad, and RP McEver Activated platelets signal chemokine synthesis by human monocytes J Clin Invest 97 1996 1525 1534
61. AS Weyrich, S Lindemann, and GA Zimmerman The evolving role of platelets in inflammation J Thromb Haemost 1 2003 1897 1905
62. AS Weyrich, MM Denis, and JR Kuhlmann-Eyre Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates Circulation 111 2005 633 642
63. BS Wung, JJ Cheng, SK Shyue, and DL Wang NO modulates monocyte chemotactic protein-1 expression in endothelial cells under cyclic strain Arterioscler Thromb Vasc Biol 21 2001 1941 1947
64. C Xiao, and S Ghosh NF-kappaB, an evolutionarily conserved mediator of immune and inflammatory responses Adv Exp Med Biol 560 2005 41 45
65. ZG Zhang, L Zhang, and W Tsang Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion Brain Res 912 2001 181 194
66. GA Zimmerman Two by two: the pairings of P-selectin and P-selectin glycoprotein ligand 1 Proc Natl Acad Sci U S A 98 2001 10023 10024